Hand and Foot Syndrome Associated with Capecitabine

Author Info

Louai Alsaloumi Shaima Shawagfeh Bilgen Başgut

Corresponding Author

Louai Alsaloumi
Department of Clinical Pharmacy, Faculty of Pharmacy, Near East University, Nicosia, Northern Cyprus, Turkey

A B S T R A C T

Having cancer impacts the patient both psychologically and physically. However, if cancer is accompanied with HFS, the patient’s condition gets even worse. Capecitabine is a prodrug approved to treat several types of cancer such as breast and colorectal cancer. It is associated with several adverse effects such as hand and foot syndrome (HFS) which mostly affects the palms and legs. The provoked mechanisms of HFS are not clear yet. They require further validation of HFS pathogenesis. Up to now, prevention and treatment of HFS are not clearly solidified. Evidence supports the use of celecoxib, urea-based creams, and vitamin E to reduce the severity and the incidence of HFS. This review aims to provide the gaps and ways to further clinical evaluations.

Article Info

Article Type

Review Article

Publication history

Received: Sat 01, Aug 2020
Accepted: Mon 17, Aug 2020
Published: Tue 25, Aug 2020

Copyright

© 2023 Louai Alsaloumi. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Hosting by Science Repository.
DOI: 10.31487/j.ACO.2020.02.03